OR2L5
Olfactory receptor 2L5
Also known as: OR2L11, OR2L5_HUMAN, OR2L5P
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NG80
- Gene
- OR2L5
- Ensembl
- ENSG00000197454
- Chromosome
- 1
- Canonical length
- 312 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
312 residues, UniProt reviewed canonical sequence.
>Q8NG80|OR2L5
1 MENYNQTSTD FILLGLFPPS KIGLFLFILF VLIFLMALIG NLSMILLIFL DTHLHTPMYF
61 LLSQLSLIDL NYISTIVPKM ASDFLYGNKS ISFIGCGIQS FFFMTFAGAE ALLLTSMAYD
121 RYVAICFPLH YPIRMSKRMY VLMITGSWMI GSINSCAHTV YAFRIPYCKS RAINHFFCDV
181 PAMLTLACTD TWVYEYTVFL SSTIFLVFPF TGIACSYGWV LLAVYRMHSA EGRKKAYSTC
241 STHLTVVTFY YAPFAYTYLC PRSLRSLTED KVLAVFYTIL TPMLNPIIYS LRNKEVMGAL
301 TRVIQNIFSV KMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OR2L5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 0.2 nTPM
- retina: 0.2 nTPM
- skeletal muscle: 0.1 nTPM
- skin: 0.1 nTPM
- spleen: 0.1 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- oligodendrocytes: 13 nCPM
- brain inhibitory neurons: 8.9 nCPM
- brain excitatory neurons: 8.7 nCPM
- hematopoietic stem cells: 8.7 nCPM
- other brain neurons: 8.7 nCPM
- oligodendrocyte progenitor cells: 6.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 7.3 nTPM
- cerebral cortex: 7 nTPM
- hypothalamus: 6.7 nTPM
- pons: 5.7 nTPM
- basal ganglia: 5.4 nTPM
- cerebellum: 5.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -1.03
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OR2L5 as an antibody target. Whether an autoantibody or antibody against OR2L5 could matter depends on whether native OR2L5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OR2L5 is annotated at the cell surface, where native OR2L5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OR2L5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...